Literature DB >> 22105363

The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity.

G O Ferrero1, F N Velazquez, B L Caputto.   

Abstract

Our previous work showed that in T98G cells, a human glioblastoma multiforme-derived cell line, the association of c-Fos to the endoplasmic reticulum (ER) and consequently, the capacity of c-Fos to activate phospholipid synthesis, is regulated by the phosphorylation state of tyrosine (tyr) residues #10 and #30 of c-Fos. The small amount of c-Fos present in quiescent cells is tyr-phosphorylated, is dissociated from the ER membranes and does not activate phospholipid synthesis. However, on induction of the cell to re-enter growth, c-Fos expression is rapidly induced, it is found dephosphorylated, associated to ER membranes and activating phospholipid synthesis (Portal et al., 2007). Herein, using in vivo and in vitro experimental strategies, we show that the kinase c-Src is capable of phosphorylating tyr residues of c-Fos whereas the phosphatase TC45 T-cell protein-tyr phosphatase (TC-PTP) dephosphorylates them, thus enabling c-Fos/ER association and activation of phospholipid synthesis. Results also suggest that the regulation of the phosphorylation/dephosphorylation cycle of c-Fos occurs at the TC-PTP level: induction of cells to re-enter growth promotes the translocation of TC45 from a nuclear to a cytoplasmic location concomitant with its activation. Activated TC45 in its turn promotes dephosphorylation of pre-formed c-Fos, enabling cells to rapidly activate phospholipid synthesis to respond to its growth demands.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105363     DOI: 10.1038/onc.2011.510

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  The moonlighting protein c-Fos activates lipid synthesis in neurons, an activity that is critical for cellular differentiation and cortical development.

Authors:  Lucia Rodríguez-Berdini; Gabriel Orlando Ferrero; Florentyna Bustos Plonka; Andrés Mauricio Cardozo Gizzi; César Germán Prucca; Santiago Quiroga; Beatriz Leonor Caputto
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

2.  Controlling cytoplasmic c-Fos controls tumor growth in the peripheral and central nervous system.

Authors:  Germán A Gil; David C Silvestre; Nicolás Tomasini; Daniela F Bussolino; Beatriz L Caputto
Journal:  Neurochem Res       Date:  2012-04-05       Impact factor: 3.996

3.  The Catalytic Efficiency of Lipin 1β Increases by Physically Interacting with the Proto-oncoprotein c-Fos.

Authors:  Andres M Cardozo Gizzi; Cesar G Prucca; Virginia L Gaveglio; Marianne L Renner; Susana J Pasquaré; Beatriz L Caputto
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

4.  Up-regulation of c-Fos associated with neuronal apoptosis following intracerebral hemorrhage.

Authors:  Xiaomei Chen; Jiabing Shen; Yang Wang; Xiaojing Chen; Shi Yu; Huili Shi; Keke Huo
Journal:  Cell Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.046

5.  MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.

Authors:  W Zhao; H He; K Ren; B Li; H Zhang; Y Lin; R-G Shao
Journal:  Blood Cancer J       Date:  2013-03-29       Impact factor: 11.037

6.  Effects of Artemisia annua L. Essential Oil on Osteoclast Differentiation and Function Induced by RANKL.

Authors:  Wen Sun; Guangyue Yang; Fang Zhang; Chenguo Feng; Mingjie Liang; Pengfei Jia; Zhongliang Zhao; Hailing Guo; Yongfang Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-07       Impact factor: 2.650

7.  Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.

Authors:  Ruben D Motrich; Gonzalo M Castro; Beatriz L Caputto
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.